CARERATING2023-07-012023-09-30 CARERATING2023-07-012023-09-30 CARERATING2023-07-012023-09-30in-bse-fin:OneOperatingExpenses01Member CARERATING2023-07-012023-09-30in-bse-fin:FourOperatingExpenses01Member CARERATING2023-09-30 CARERATING2023-07-012023-09-30in-bse-fin:OneReportableSegmentRevenue01Member CARERATING2023-07-012023-09-30in-bse-fin:OneReportableSegmentRevenue02Member CARERATING2023-07-012023-09-30in-bse-fin:FourReportableSegmentRevenue01Member CARERATING2023-07-012023-09-30in-bse-fin:FourReportableSegmentRevenue02Member CARERATING2023-07-012023-09-30in-bse-fin:OneReportableSegmentResults01Member CARERATING2023-07-012023-09-30in-bse-fin:OneReportableSegmentResults02Member CARERATING2023-07-012023-09-30in-bse-fin:FourReportableSegmentResults01Member CARERATING2023-07-012023-09-30in-bse-fin:FourReportableSegmentResults02Member CARERATING2023-07-012023-09-30in-bse-fin:OneReportableSegmentAssets01Member CARERATING2023-07-012023-09-30in-bse-fin:OneReportableSegmentAssets02Member CARERATING2023-07-012023-09-30in-bse-fin:OneReportableSegmentLiabilities01Member CARERATING2023-09-30in-bse-fin:OneReportableSegmentLiabilities01Member CARERATING2023-07-012023-09-30in-bse-fin:OneReportableSegmentLiabilities02Member CARERATING2023-09-30in-bse-fin:OneReportableSegmentLiabilities02Member CARERATING2023-07-012023-09-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member CARERATING2023-07-012023-09-30in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member CARERATING2023-07-012023-09-30in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member CARERATING2023-07-012023-09-30in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 534804 CARERATING NA CARE Ratings Limited Equity 2023-04-01 2024-03-31 2023-10-31 2023-10-17 INR Lakhs Half yearly 13:00:00 19:05:00 2023-10-31 2023-10-31 true Cash Flow Indirect Not applicable Multi segment 2023-07-01 2023-09-30 Unaudited Consolidated 964414000.00 111867000.00 1076281000.00 0.00 0.00 0.00 404553000.00 4062000.00 26324000.00 140742000.00 575682000.00 500600000.00 0.00 500600000.00 139280000.00 3982000.00 143262000.00 0.00 357338000.00 0.00 0.00 0.00 0.00 357338000.00 2203000.00 359541000.00 351742000.00 5596000.00 353757000.00 5784000.00 297729000.00 10 11.83 11.79 0.00 0.00 11.83 11.79 1. The above results have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at its meeting held on October 31, 2023 and have been subjected to limited review by the statutory auditors of the Company. 2. The Board of Directors of the Company have recommended interim dividend of Rs. 7/- per share. 3. The consolidated financial results include results of CARE Ratings Limited and its subsidiaries namely CARE Analytics and Advisory Private Limited (formerly known as CARE Risk Solutions Private Limited), CARE Advisory Research and Training Limited, CARE Ratings (Africa) Private Limited and CARE Ratings Nepal Limited. 4. The accompanying financial results have been prepared as per the format prescribed under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as modified by Circular No. CIR/CFD/FAC/62/2016. 5. The financial results have been prepared in accordance with the applicable accounting standards, as modified under the Companies (Indian Accounting Standards) Rules, 2015 and as specified in section 133 of the Companies Act. 6. On September 30, 2023 the Board of Directors of the Company, CARE Advisory Research and Training Limited (CART) and CARE Analytics and Advisory Private Limited (formerly known as CARE Risk Solutions Private Limited) (CAAPL), both wholly own subsidaries of the company, approved the transfer of the existing advisory business from CART to CAAPL via a slump sale basis for a cash consideration of INR 481 lakhs. The said slump sale was concluded on October 16, 2023. 7. The Company has granted a) 5,00,000 options on October 13, 2020, b) 3,22,000 options on December 01, 2020, c) 1,23,500 options on October 29, 2021, d) 25,000 options on May 28, 2022, e) 1,00,000 options on July 29, 2022, f) 72,000 options on November 8, 2022, g) 10,000 options on January 04, 2023, h) 1,05,000 options on September 27, 2023 and i) 6,000 options on September 30, 2023 to the eligible employees as the Company's Employees Stock Option Scheme (ESOS) 2020 duly approved by shareholders in AGM and Nomination and Remuneration Committee. The closing balance of options as on 30th September, 2023 are 4,92,079. As per Ind AS 102 - Share Based Payment, total cost of ESOP will be charged over vesting period, accordingly the Employee Benefit Expenses in standalone results includes ESOP charge under respective periods as under: Particulars Quarter Ended Six Months Ended Year ended September 30, 2023 June 30, 2023 September 30, 2022 September 30, 2023 September 30, 2022 March 31, 2023 Unaudited Unaudited Unaudited Unaudited Unaudited Audited Share based payment expenses 57.16 64.21 117.65 121.37 (97.28) 14.73 Multi segment 2023-04-01 2023-09-30 Unaudited Consolidated 1628601000.00 227200000.00 1855801000.00 0.00 0.00 0.00 788369000.00 7868000.00 52050000.00 242776000.00 1091062000.00 764739000.00 0.00 764739000.00 216838000.00 7007000.00 223845000.00 0.00 540894000.00 0.00 0.00 0.00 0.00 540894000.00 686000.00 541580000.00 529841000.00 11053000.00 530247000.00 11333000.00 297729000.00 10 17.83 17.78 0.00 0.00 17.83 17.78 Other Expenses 140742000.00 Other Expenses 242776000.00 78564000.00 811809000.00 0.00 0.00 79503000.00 219379000.00 64903000.00 0.00 0.00 426634000.00 0.00 3385000.00 108197000.00 538216000.00 0.00 3687000.00 1717497000.00 0.00 0.00 514183000.00 956838000.00 37980000.00 4677000.00 4602574000.00 6116252000.00 63515000.00 244091000.00 6423857000.00 0.00 0.00 8141354000.00 297729000.00 6542603000.00 6840332000.00 6918896000.00 0.00 0.00 183692000.00 183692000.00 124025000.00 55839000.00 0.00 0.00 363555000.00 0.00 108736000.00 158468000.00 267204000.00 452092000.00 53713000.00 85894000.00 0.00 858904000.00 0.00 0.00 1222459000.00 8141354000.00 Others 72939000.00 Ratings and related services 891755000.00 Others 137533000.00 Ratings and related services 1492776000.00 964694000.00 1630308000.00 280000.00 1707000.00 964414000.00 1628601000.00 Others -60205000.00 Ratings and related services 452999000.00 Others -110849000.00 Ratings and related services 656256000.00 392794000.00 545407000.00 4062000.00 7868000.00 -111867000.00 -227200000.00 500600000.00 764739000.00 Others 467383000.00 Ratings and related services 7167834000.00 7635217000.00 506137000.00 8141354000.00 Others 167321000.00 Ratings and related services 1055136000.00 1222457000.00 0.00 1222457000.00 7868000.00 0.00 -288540000.00 0.00 -31824000.00 -104638000.00 0.00 0.00 0.00 0.00 0.00 88359000.00 0.00 52050000.00 0.00 0.00 0.00 -33858000.00 114183000.00 -1390000.00 3474000.00 196889000.00 14421000.00 -279000.00 0.00 0.00 0.00 -16239000.00 0.00 -400250000.00 364488000.00 0.00 0.00 0.00 152655000.00 0.00 211834000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 63547000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1398625000.00 712000000.00 0.00 0.00 0.00 0.00 3474000.00 58095000.00 0.00 0.00 0.00 684647000.00 0.00 0.00 32030000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 10364000.00 447987000.00 0.00 0.00 -7568000.00 -433889000.00 462591000.00 0.00 462591000.00 494247000.00 956838000.00 Items that will not be reclassified to profit and loss 1791000.00 Items that will not be reclassified to profit and loss -763000.00 1791000.00 -763000.00 444000.00 -171000.00 Items that will be reclassified to profit and loss 857000.00 Items that will be reclassified to profit and loss 1279000.00 857000.00 1279000.00 0.00 0.00